Intrinsic drug resistance in primary and metastatic renal cell carcinoma

Journal of Urology

Volumn 162, Issue 1, 1999, Pages 217-224

  Gamelin, E ^a   Mertins, S D ^a   Regis, J T ^a   Mickley, L ^a   Abati, A ^a   Worrell, R A ^a   Linehan, W M ^a   Bates, S E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Metastases; Multi drug resistance; Renal carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; CALCEIN; CYTOKERATIN; DACTINOMYCIN; DEPSIPEPTIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ETOPOSIDE; GLYCOPROTEIN P; INTERMEDIATE FILAMENT PROTEIN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; PACLITAXEL; RHODAMINE; RIBONUCLEASE;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; METASTASIS; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032863685     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005392-199907000-00071     Document Type: Article

References (36)

1. Lehnert M. Clinical multidrug resistance in cancer: a multifactorial problem Eur. J. Cancer 32A 1996 912
2. Yagoda A. Abi-Rached B. Petrylak D. Chemotherapy for advanced renal-cell carcinoma: 1983-1993 Semin. Oncol. 22 1995 42
3. Pritchard J.B. Miller D.S. Mechanisms mediating renal secretion of organic anions and cations Am. J. Physiol. 73 1993 765
4. Fojo A.T. Ueda K. Slamon D.J. Poplack D.G. Gottesman M.M. Pastan I. Expression of a multidrug resistance gene in human tumors and tissues Proc. Natl. Acad. Sci. USA 84 1987 265
5. Tasken K. Kvale D. Hansson V. Jahnsen T. Protein kinase C activation selectively increases mRNA levels for one of the regulatory subunits (RIalpha) of cAMP-dependent protein kinases in HT-29 cells Biochem. Biophys. Res. Comm. 172 1990 409
6. Naito S. Sakamoto N. Kotoh S. Goto K. Matsumoto T. Kumazawa J. Expression of P-glycoprotein and multidrug resistance in renal cell carcinoma Eur. Urol. 24 1993 156
7. Rochlitz C.F. Jobeck H. Peter S. Reuter J. Mohr B. de Kant E. Huhn D. Herrmann R. Multiple drug resistance gene expression in human renal cell cancer is associated with the histologic subtype Cancer 69 1992 2993
8. Kanamaru H. Kakehi Y. Yoshida O. Nakanishi S. Pastan I. Gottesman M.M. MDR1 RNA levels in human renal cell carcinomas: correlation with grade and prediction of reversal of doxorubicin resistance by quinidine in tumor explants J Natl. Cancer Inst. 81 1989 844
9. Fojo A.T. Shen D.-W. Mickley L.A. Pastan I. Gottesman M.M. Intrinsic drug resistance in human kidney cancer is associated with expression of a human multidrug resistance gene J. Clin. Oncol. 5 1987 1922
10. Nishiyama K. Shirahama T. Yoshimura A. Sumizawa T. Furukawa T. Ichikawa-Haraguchi M. Akiyama S. Ohi Y. Expression of the multidrug transporter, P-glycoprotein, in renal and transitional cell carcinomas Cancer 71 1993 3611
11. Kakehi Y. Kanamaru H. Yoshida O. Ohkubo H. Nakanishi S. Gottesman M.M. Pastan I. Measurement of multidrug-resistance messenger RNA in urogenital cancers; elevated expression in renal cell carcinoma is associated with intrinsic drug resistance J. Urol. 139 1988 862
12. Bak M. Jr Efferth T. Mickisch G. Mattern J. Volm M. Detection of drug resistance and P-glycoprotein in human renal cell carcinomas Eur. Urol. 17 1990 72
13. Volm M. Kastel M. Mattern J. Efferth T. Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas Cancer 71 1993 3981
14. Mickish G.H. Roehrich K. Koessig J. Forster S. Tschada R.K. Alken P.M. Mechanisms and modulation of multidrug resistance in primary renal cell carcinoma J. Urol. 144 1990 755
15. Kang Y.K. Zhan Z. Regis J. Robey R. Meadows B. Dickstein B. Lee J.S. Otsuki T. Stetler-Stevenson M.A. Jaffe E.S. Solomon D. Wilson W.H. Fojo A. Bates S.E. Expression of mdr-1 in refractory lymphoma: quantitation by polymerase chain reaction and validation of the assay Blood 86 1995 1515
16. Gnarra J.R. Tory K. Weng Y. Schmidt L. Wei M.H. Li H. Latif F. Liu S. Chen F. Duh F.M. Lubensky I. Duan D.R. Florence C. Pozzatti R. Walther M.W. Bander N.H. Grossman H.B. Brauch H. Pomer S. Brooks J.D. Isaacs W.B. Lerman M.I. Zbar B. Linehan W.M. Mutation of the VHL tumour suppressor gine in renal carcinoma Nat. Gen. 7 1994 85
17. Zhao W.P. Gnarra J.R. Knutsen T. Linehan W.M. Whang-Peng J. Renal cell carcinoma. Cytogenetic analysis of tumors and cell lines Cancer Genet. Cytogenet. 82 1995 128
18. Herman J.G. Latif F. Weng Y. Lerman M.I. Zbar B. Liu S. Samid D. Duan D.-S.R. Gnarra J. Linehan W.M. Baylin S.B. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma Proc. Natl. Acad. Sci. USA 91 1994 9700
19. Mydlo J.H. Michaeli J. Cordon-Cardo C. Goldenberg A.S. Heston W.D.W. Fair W.R. Expression of transforming growth factor a and epidermal growth factor receptor messenger RNA in neoplastic and nonneoplastic human kidney tissue Cancer Res. 49 1989 3407
20. Freeman M.R. Washecka R. Chung L.W. K Aberrant expression of epidermal growth factor receptor and HER-2 (erbB-2) messenger RNA's in human renal cancers Cancer Res. 49 1989 6221
21. Lai G.-M. Chen Y.-N. Mickley L.A. Fojo A.T. Bates S.E. P-glycoprotein expression and schedule dependence of Adriamycin cytotoxicity in human colon carcinoma cell lines Int. J. Cancer 49 1991 696
22. Zhan Z. Sandor V.A. Gamelin E. Regis J. Dickstein B. Wilson W. Fojo A.T. Bates S.E. Expression of the multidrug resistance-associated protein gene in refractory lymphoma: quantitation by a validated polymerase chain reaction assay Blood 89 1997 3795
23. Ulrich A. Coussens L. Hayflick J.S. Dull T.J. Gray A. Tam A.W. Lee J. Yarden Y. Libermann T.A. Schlessinger J. Downward J. Mayes E.L. Whittle N. Waterfield M.D. Seeburg P.H. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells Nature 309 1984 418
24. Mickley L.A. Bates S.E. Richert N.D. Currier S. Tanaka S. Foss F. Rosen N. Fojo A.T. Modulation of the expression of a multidrug resistance gene (mdr-1/P-glycoprotein) by differentiating agents J. Biol. Chem. 264 1989 18031
25. Skehan P. Storeng R. Scudiero D. Monks A. McMahon J. Vistica D. Warren J.T. Bokesch H. Kenney S. Boyd M.R. New colorimetric cytotoxicity assay for anticancer-drug screening J. Natl. Cancer Inst. 82 1990 1107
26. R) in doxorubicin or mitoxantrone refractory breast cancer J. Clin. Oncol. 12 1994 1621
27. Feller N. Kuiper C.M. Lankelma J. Ruhdal J.K. Scheper R.J. Pinedo H.M. Broxterman H.J. Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumor cells by flow cytometry Br. J. Cancer 72 1995 543
28. Bauman P.A. Dalton W.S. Anderson J.M. Cress A.E. Expression of cytokeratin confers multiple drug resistance Proc. Natl. Acad. Sci. USA. 91 1994 5311
29. Lee J.S. Paull K. Alvarez M. Hose C. Monks A. Grever M. Fojo A.T. Bates S.E. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute Drug Screen Mol. Pharmacol. 46 1994 627
30. Alvarez M. Robey R. Sandor V. Nishiyama K. Matsumoto Y. Paull K. Bates S. Fojo T. Using the NCI anticancer drug screen to assess the effect of MRP expression on drug sensitivity profiles Mol. Pharmacol. 95 1998 2205
31. Bates S.E. Mickley L.A. Chen Y.-N. Richert N. Rudick J. Biedler J.L. Fojo A.T. Expression of a drug resistance gene in human neuroblastoma cell lines: modulation by retinoic acid-induced differentiation Mol. Cell. Biol 9 1989 4337
32. van Kalken C.K. van der Valk P. Hadisaputro M.M.N. Pieters R. Broxterman H.J. Kuiper C.M. Scheffer G.L. Veerman A.J.P. Meyers C.J.L.M. Scheper R.J. Pinedo H.M. Differentiation dependent expression of P-glycoprotein in the normal and neoplastic human kidney Ann. Oncol. 2 1991 55
33. Moll R. Hage C. Thoenes W. Expression of intermediate filament proteins in fetal and adult human kidney: modulations of intermediate filament patterns during development and in damaged tissue Lab. Invest. 65 1991 74
34. Oosterwijk E. Van Muijen G.N.P. Oosterwijk-wakka J.C. Warnaar S.O. Expression of intermediate-sized filaments in developing and adult human kidney and in renal cell carcinoma J. Histochem. Cytochem. 38 1990 385
35. Ward J.M. Stevens J.L. Konishi N. Kurata Y. Uno H. Diwan B.A. Ohmori T. Vimentin metaplasia in renal cortical tubules of preneoplastic, neoplastic, aging, and regenerative lesions of rats and humans Am. J. Pathol. 141 1992 955
36. Weinstein R.S. Jakate S.M. Dominguez J.M. Lebovitz M.D. Koukoulis G.K. Kuszak J.R. Klusens L.F. Grogran T.M. Saclarides T.J. Roninson I.B. Relationship of the expression of the multidrug resistance gene product (P-Glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis Cancer Res. 51 1991 2720